Growth Metrics

Insulet (PODD) Gross Profit (2016 - 2025)

Insulet filings provide 16 years of Gross Profit readings, the most recent being $568.6 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 31.96% to $568.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 billion, a 34.18% increase, with the full-year FY2025 number at $1.9 billion, up 34.18% from a year prior.
  • Gross Profit hit $568.6 million in Q4 2025 for Insulet, up from $510.1 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $568.6 million in Q4 2025 to a low of $167.5 million in Q1 2021.
  • Median Gross Profit over the past 5 years was $279.1 million (2023), compared with a mean of $305.2 million.
  • Biggest five-year swings in Gross Profit: decreased 0.21% in 2022 and later surged 66.22% in 2023.
  • Insulet's Gross Profit stood at $213.2 million in 2021, then grew by 1.92% to $217.3 million in 2022, then surged by 66.22% to $361.2 million in 2023, then increased by 19.3% to $430.9 million in 2024, then skyrocketed by 31.96% to $568.6 million in 2025.
  • The last three reported values for Gross Profit were $568.6 million (Q4 2025), $510.1 million (Q3 2025), and $452.2 million (Q2 2025) per Business Quant data.